Work

Results from a phase Ib/II study of enzalutamide and metformin in men with castration resistant prostate cancer (CRPC).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.5054

Authors: Mamta Parikh, Daniel Robles, Chong-xian Pan, Primo Lara, Joy C Yang, Allen Gao, Christopher P. Evans

Institutions: UC Davis Comprehensive Cancer Center, University of California, Davis

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947557484

Cites:

Cited by: 6

Related to: 10